Feasibility and Acceptability of Early Linkage to HCV Treatment in Pregnancy Feasibility and Acceptability of Early Linkage to HCV Treatment in Pregnancy
Latest Information Update: 19 Jun 2026
At a glance
- Drugs Glecaprevir/pibrentasvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions
Most Recent Events
- 09 Jun 2026 Planned End Date changed from 28 Feb 2026 to 28 Dec 2026.
- 09 Jun 2026 Planned primary completion date changed from 28 Feb 2026 to 28 Dec 2026.
- 18 Apr 2024 New trial record